The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening

Hepatitis B Clinical Trial

Official title:

The Effect of an Electronic Medical Record (EMR) Alert on Hepatitis B Screening: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04240678
• Other study ID #: 8301387
• Status: Completed
• Phase: N/A
• Start date: January 1, 2016
• Est. completion date: July 1, 2021

Study information

• Verified date: August 2021
• Source: University of California, Davis
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Asian and Pacific Islander Americans at risk, but never tested for chronic hepatitis B have been randomized to receive an electronic alert in their electronic medical chart to remind primary care physicians to screen them for chronic hepatitis B.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 8299
• Est. completion date: July 1, 2021
• Est. primary completion date: July 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria: Asian and Pacific Islanders (API) who have not yet received HBsAg testing. API will be identified using a novel algorithm which identifies them using their surname, language preference, country of origin. - Exclusion Criteria: Previous HBsAg completion. -

Related Conditions & MeSH terms

• Hepatitis
• Hepatitis A
• Hepatitis B

Intervention

Other:
• Electronic HBV Alert
Electronic HBV Alert deployed in electronic medical charts of at risk patients

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of California, Davis

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Serum Hepatitis B Surface Antigen Completion	Number of patients who have completed the HBsAg test	up to 12 months
Secondary	Serum Hepatitis B Surface Antigen Positivity	Number of patients with testing positive for HBsAg	up to 12 months